The NVMBQ provides a good basis for assessing patient-related barriers to chemotherapy-induced nausea and vomiting management.
Nausea and Vomiting Management Barriers Questionnaire (NVMBQ)
NUMBER OF ITEMS:
Cancer patients 18 years and older with chemotherapy-induced nausea and vomiting
Paper and electronic
Self-administration and interview when applicable
TIME FOR COMPLETION:
Available translations of the NVMBQ can be obtained when licensing the measure. Users are not permitted to translate the NVMBQ without prior permission from FACIT.org. Permission may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor of the NVMBQ.
Please contact us for more information.
Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.
Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.
To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.
Haselmayer D, Salsman JM, Cella D, Koller A. Psychometric Evaluation of the Patient-Related Nausea and Vomiting Management Barriers Questionnaire. J Pain Symptom Manage. 2020 Aug;60(2):439-448. doi: 10.1016/j.jpainsymman.2020.03.032. Epub 2020 Apr 8. PMID: 32276096.